Celularity Inc. Terminates Material Definitive Agreement
Ticker: CELUW · Form: 8-K · Filed: Jan 24, 2025 · CIK: 1752828
Sentiment: neutral
Topics: termination, agreement
Related Tickers: CELU
TL;DR
Celularity just terminated a big deal, could be bad news.
AI Summary
Celularity Inc. announced on January 23, 2025, the termination of a material definitive agreement. The company, formerly known as GX Acquisition Corp., is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
The termination of a material definitive agreement can significantly impact a company's financial standing and future operational plans, potentially affecting its stock value and strategic direction.
Risk Assessment
Risk Level: medium — Termination of a material definitive agreement often signals significant business challenges or a change in strategic direction, which can introduce uncertainty and risk.
Key Players & Entities
- Celularity Inc. (company) — Registrant
- GX Acquisition Corp. (company) — Former company name
- January 23, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Florham Park, New Jersey (location) — Principal executive offices address
FAQ
What was the specific material definitive agreement that Celularity Inc. terminated?
The filing does not specify the details of the material definitive agreement that was terminated.
When was the termination of the material definitive agreement effective?
The filing indicates January 23, 2025, as the date of the earliest event reported, which is the termination.
What is Celularity Inc.'s primary business sector?
Celularity Inc. operates in the Pharmaceutical Preparations sector, with SIC code 2834.
What was Celularity Inc.'s former company name?
Celularity Inc.'s former company name was GX Acquisition Corp.
Where are Celularity Inc.'s principal executive offices located?
Celularity Inc.'s principal executive offices are located at 170 Park Ave, Florham Park, New Jersey, 07932.
Filing Stats: 525 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-01-24 17:17:42
Key Financial Figures
- $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share CELU The Nasdaq
- $11.50 — A Common Stock at an exercise price of $11.50 per share CELUW The Nasdaq Stock Ma
- $2.375 — 's Common Stock, at a purchase price of $2.375 per share of Common Stock and accompany
Filing Documents
- form8-k.htm (8-K) — 42KB
- 0001493152-25-003635.txt ( ) — 262KB
- celu-20250123.xsd (EX-101.SCH) — 4KB
- celu-20250123_def.xml (EX-101.DEF) — 29KB
- celu-20250123_lab.xml (EX-101.LAB) — 36KB
- celu-20250123_pre.xml (EX-101.PRE) — 27KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELULARITY INC . Dated: January 24, 2025 By: /s/ Robert J. Hariri Name: Robert J. Hariri, M.D., Ph.D. Title: Chairman and CEO -3-